Ocular Therapeutix, Inc. (OCUL) Ownership

$0.00

$0 (0%)
Last update: 07:00 PM EST
Day's range
$9.77
Day's range
$10.25

Ocular Therapeutix Inc Major Shareholders & Ownership History

Major Shareholder Name Reporting Date Shares Held Market Value Change in Shares Ownership
FMR LLC 08/13/2026 32.84 M $322.53 M   0.58% 14.60%
DEEP TRACK CAPITAL, LP 08/14/2026 19.69 M $193.32 M   0.00% 8.75%
BLACKROCK, INC. 08/07/2026 19.38 M $190.28 M   20.11% 8.61%
AVORO CAPITAL ADVISORS LLC 08/14/2026 12.54 M $123.14 M   1.83% 5.57%
SUMMER ROAD LLC 08/10/2026 12.21 M $119.89 M   2.76% 5.43%
VR ADVISER, LLC 08/14/2026 10.35 M $101.61 M   0.00% 4.60%
VANGUARD CAPITAL MANAGEMENT LLC 08/13/2026 8.83 M $86.74 M   1.30% 3.93%
PRICE T ROWE ASSOCIATES INC /MD/ 08/14/2026 7.62 M $74.86 M   29.27% 3.39%
LOGOS GLOBAL MANAGEMENT LP 08/14/2026 5.30 M $52.05 M   37.66% 2.36%
STATE STREET CORP 08/07/2026 5.23 M $51.39 M   11.15% 2.33%
GEODE CAPITAL MANAGEMENT, LLC 08/12/2026 5.02 M $49.32 M   10.86% 2.23%
POINT72 ASSET MANAGEMENT, L.P. 08/14/2026 3.29 M $32.33 M   -40.52% 1.46%
DIMENSIONAL FUND ADVISORS LP 08/11/2026 2.78 M $27.33 M   328.37% 1.24%
DELTEC ASSET MANAGEMENT LLC 07/21/2026 2.48 M $24.32 M   5.79% 1.10%
BALYASNY ASSET MANAGEMENT L.P. 08/14/2026 2.27 M $22.30 M   -15.67% 1.01%
OCTAGON CAPITAL ADVISORS LP 08/14/2026 2.08 M $20.38 M   -34.47% 0.92%
VANGUARD PORTFOLIO MANAGEMENT LLC 08/13/2026 1.97 M $19.38 M   23.73% 0.88%
NORTHERN TRUST CORP 08/13/2026 1.80 M $17.67 M   17.95% 0.80%
GOLDMAN SACHS GROUP INC 08/14/2026 1.76 M $17.30 M   58.66% 0.78%
NUVEEN, LLC 08/11/2026 1.70 M $16.67 M   312.88% 0.75%
WOODLINE PARTNERS LP 08/14/2026 1.67 M $16.38 M   0.00% 0.74%
TCG CROSSOVER MANAGEMENT, LLC 08/14/2026 1.65 M $16.18 M   0.00% 0.73%
UBS GROUP AG 08/13/2026 1.55 M $15.23 M   2.00% 0.69%
ADAGE CAPITAL PARTNERS GP, L.L.C. 08/14/2026 1.55 M $15.22 M   100.00% 0.69%
CHARLES SCHWAB INVESTMENT MANAGEMENT INC 08/14/2026 1.53 M $15.06 M   4.95% 0.68%
SIXTH STREET PARTNERS MANAGEMENT COMPANY, L.P. 08/14/2026 1.53 M $15.06 M   100.00% 0.68%
DEFILADE CAPITAL MANAGEMENT, L.P. 08/14/2026 1.49 M $14.63 M   0.18% 0.66%
SQUAREPOINT OPS LLC 08/14/2026 1.42 M $13.90 M   44.37% 0.63%
INVESCO LTD. 08/14/2026 1.34 M $13.20 M   -12.52% 0.60%
BOXER CAPITAL MANAGEMENT, LLC 08/14/2026 1.30 M $12.77 M   271.43% 0.58%
VANGUARD FIDUCIARY TRUST CO 08/13/2026 1.29 M $12.66 M   3.55% 0.57%
TWO SIGMA INVESTMENTS, LP 08/14/2026 1.22 M $11.97 M   -33.42% 0.54%
KNOLL CAPITAL MANAGEMENT, LLC 09/10/2026 1.15 M $11.30 M   91.61% 0.51%
HRT FINANCIAL LP 08/14/2026 1.08 M $10.58 M   51.87% 0.48%
BALYASNY ASSET MANAGEMENT L.P. 08/14/2026 975.20 K $9.58 M   100.00% 0.43%
RAYMOND JAMES FINANCIAL INC 08/14/2026 963.32 K $9.46 M   12.08% 0.43%
AQR CAPITAL MANAGEMENT LLC 08/14/2026 950.34 K $9.33 M   90.32% 0.42%
MORGAN STANLEY 08/13/2026 911.83 K $8.95 M   -28.77% 0.41%
CANDRIAM S.C.A. 08/13/2026 907.84 K $8.91 M   -4.36% 0.40%
EMPIRE LIFE INVESTMENTS INC. 07/24/2026 871.69 K $8.56 M   -1.43% 0.39%
CETERA INVESTMENT ADVISERS 08/12/2026 785.73 K $7.72 M   2.76% 0.35%
PEREGRINE CAPITAL MANAGEMENT LLC 07/17/2026 753.50 K $7.40 M   4.59% 0.34%
APTUS CAPITAL ADVISORS, LLC 08/12/2026 638.69 K $6.27 M   20.56% 0.28%
SECOND LINE CAPITAL, LLC 09/02/2026 638.64 K $6.27 M   20.89% 0.28%
OPALEYE MANAGEMENT INC. 08/14/2026 600.00 K $5.89 M   0.00% 0.27%
ALGERT GLOBAL LLC 08/13/2026 592.31 K $5.82 M   9.90% 0.26%
BANK OF NEW YORK MELLON CORP 08/06/2026 553.24 K $5.43 M   16.23% 0.25%
MAN GROUP PLC 08/14/2026 543.58 K $5.34 M   206.30% 0.24%
SIO CAPITAL MANAGEMENT, LLC 08/14/2026 539.49 K $5.30 M   -44.30% 0.24%
ACUTA CAPITAL PARTNERS, LLC 08/14/2026 532.48 K $5.23 M   -10.07% 0.24%

Ocular Therapeutix Inc institutional Ownership - FAQ's

During the previous two years, 348 institutional investors and hedge funds held shares of Ocular Therapeutix Inc. The most heavily invested institutionals were:

FMR LLC: 32.84 M

Deep Track Capital, LP: 19.69 M

BlackRock, Inc.: 19.38 M

Avoro Capital Advisors LLC: 12.54 M

SUMMER ROAD LLC: 12.21 M

VR Adviser, LLC: 10.35 M

92.79% of Ocular Therapeutix Inc stock is owned by institutional investors.

Institutional investors have bought a total of 236.24 M shares in the last 24 months. This purchase volume represents approximately $2.35 B in transactions.